Assessment of superiority of HSP70-targeting aptamer-functionalized drug-nanocarrier over non-targeted commercially available counterpart in HCC therapy: in vitro and in vivo investigations and molecular modeling-Reference-Cited by-同舟云学术

Assessment of superiority of HSP70-targeting aptamer-functionalized drug-nanocarrier over non-targeted commercially available counterpart in HCC therapy: in vitro and in vivo investigations and molecular modeling

Published:2023-03 Issue: Volume:317 Page:121467
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Chakraborty Samrat,Chakraborty Apala,Mukherjee Biswajit,Besra Shila Elizabeth,Dewanjee Saikat,Mukherjee Alankar,Sen Ramkrishna,Ojha Probir Kumar,Kumar Vinay,Shaw Tapan Kumar,Ghosh Prasanta,Debnath Mita Chatterjee,Ghosh Miltu Kumar

Funder

University Grants Commission

CSIR - Indian Institute of Chemical Biology

Jadavpur University

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference44 articles.

1. Apigenin-loaded galactose tailored PLGA nanoparticles: a possible strategy for liver targeting to treat hepatocellular carcinoma;Ganguly;Colloids Surf. B. Biointerfaces,2021

2. The immunological and metabolic landscape in primary and metastatic liver cancer;Li;Nat. Rev. Cancer,2021

3. Metabolic reprogramming of immune cells: shaping the tumor microenvironment in hepatocellular carcinoma;Xia;Cancer Med.,2021

4. Metabolic rearrangements in primary liver cancers: cause and consequences;Satriano;Nat. Rev. Gastroenterol. Hepatol.,2019

5. Hepatocellular carcinoma: diagnosis, molecular pathogenesis, biomarkers, and conventional therapy;Mukherjee,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma;Heliyon;2024-01